Benefit brokers have a growing opportunity to help clients incorporate comparative effectiveness research into value-based health plan design, a just-released survey suggests. They will, however, have to gain ground on other resources employers are turning to in their search for the most trusted adviser.
Employers have, for some time, expressed desires to reward use of the most effective treatments for containing costs and restoring workers’ health. But a survey commissioned by the National Pharmaceutical Council offers new insight on employers’ desire to bring CER to bear on plan design.
Register or login for access to this item and much more
All Employee Benefit Adviser content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access